Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) in the first-line treatment of MCRC: Opus, a phase II studyG. Schuch, E. Staroslawska,M. Nowacki, I. Mitashok, E. Kuznetsova, P. Cortes, C. Giron, O. Tarasova,A. Zubel, Y. ShparykANNALS OF ONCOLOGY（2007）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
